Thursday, January 26, 2023
12:30 PM – 1:00 PM | Light Snacks and Registration – Frontenac Foyer |
1:00 PM | Welcome to SHOW – Dr. David Liu – Frontenac Ballroom AB |
1:00 PM – 5:10 PM | mCRC – Chair: Dr. Andrew Kennedy |
1:00 PM – 1:15 PM | Introduction and Cases – Dr. Andrew Kennedy, Nashville, TN |
1:20 PM – 1:35 PM | Current mCRC Paradigms – Dr. Benjamin Weinberg, Washington, DC |
1:35 PM – 1:40 PM | Questions & Answers |
1:40 PM – 1:55 PM | Resection and Ablation for Metastatic Colon Cancer to the Liver – Dr. Jean-Nicolas Vauthey, Houston, TX |
1:55 PM – 2:00 PM | Questions & Answers |
2:00 PM – 2:15 PM | Combining Y90 and Systemic Therapies: Updates and Cautions – Dr. Andrew Kennedy, Nashville, TN |
2:15 PM – 2:20 PM | Questions & Answers |
2:20 PM – 2:55 PM | Panel: What Locoregional Therapy and When? – Chair: Dr. R. Lewandowski Panelists: Dr. G. Narayanan, Dr. N. Sharma, Dr. J.N Vauthey, Dr. B. Weinberg |
2:55 PM – 3:10 PM | Refreshment Break – Frontenac Foyer |
3:15 PM – 3:30 PM | Biomarker Testing for mCRC and Implications for Liver Directed Therapies – Dr. Benjamin Weinberg, Washington, DC |
3:30 PM – 3:35 PM | Questions & Answers |
3:35 PM – 3:50 PM | Is Embolotherapy still Relevant in mCRC? – Dr. Govindarajan Narayanan, Miami, FL |
3:50 PM – 3:55 PM | Questions & Answers |
3:55 PM – 4:10 PM | Optimization of Resection: Mgt of Synchronous Metastatic from Colorectal Cancer – Dr. Jean-Nicolas Vauthey, Houston, TX |
4:10 PM – 4:15 PM | Questions & Answers |
4:15 PM – 4:30 PM | Transplant, Liver Function and the Era of Immunooncology – Dr. Vladimir Marquez, Vancouver, BC |
4:30 PM – 4:35 PM | Questions & Answers |
4:35 PM – 5:10 PM | Panel Cases – Chair: Dr. A. Kennedy Panelists: Dr. K. Cuneo, Dr. R. Lewandowski, Dr. J.N. Vauthey, Dr. B. Weinberg |
5:15 PM – 7:30 PM | SHOW Welcome Reception (Dinner)- Frontenac Foyer |
Friday, January 27, 2023
6:30 AM – 7:30 AM |
Breakfast- Frontenac Ballroom C |
7:30 AM – 11:55 AM |
HCC Part 1 – Evidence – Chair: Dr. David Liu- Frontenac AB |
7:30 AM – 7:45 AM | Introduction and Cases – Dr. David Liu, Vancouver, BC |
7:50 AM – 8:05 AM | Review of HCC and Embolotherapy: The Last 10 years – Dr. David Liu, Vancouver, BC |
8:05 AM – 8:10 AM | Questions & Answers |
8:10 AM – 8:25 AM | Where does Transplant Fit? Criteria and Controversies – Dr. Ian McGilvray, Toronto, ON |
8:25 AM – 8:30 AM | Questions & Answers |
8:30 AM – 8:45 AM | Level 1 Evidence for Systemic Therapy in HCC: What Have We Learned – Dr. Howard Lim, Vancouver, BC |
8:45 AM – 8:50 AM | Questions & Answers |
8:50 AM – 9:05 AM | Technology Updates in Radiation Therapy for Hepatobiliary Tumors – Dr. Navesh Sharma, Penn State, PA |
9:05 AM – 9:10 AM | Questions & Answers |
9:10 AM – 9:45 AM | Panel: Mitigating Upstream and Downstream Toxicity in Localized Pancreatic Cancer – Chair: Dr. D. Renouf Panelists: Dr. I. McGilvary, Dr. V. Marquez, Dr. N. Sharma, Dr. J. Wong |
9:45 AM – 10:00 AM | Refreshment Break – Frontenac Foyer |
10:00 AM- 10:15 AM | Locoregional and Systemic Options for Downstaging HCC to Resection or Transplant – Dr. Robert Lewandowski, Chicago, IL |
10:15 AM – 10:20 AM | Questions & Answers |
10:20 AM – 10:35 AM | Curative Intent Therapies: Surgical Edition – Dr. Ian McGilvray, Toronto, ON |
10:35 AM – 10:40 AM | Questions & Answers |
10:40 AM – 10:55 AM | Curative Intent Therapies: IR Edition – Dr. Robert Lewandowski, Chicago, IL |
10:55 AM – 11:00 AM | Questions & Answers |
11:00 AM – 11:15 AM | MDT in HCC: from the Med Onc Perspective – Dr. Howard Lim, Vancouver, BC |
11:15 AM – 11:20 AM | Questions & Answers |
11:20 AM – 11:35 AM | Hepatitis and HCC from a Hepatology Perspective – Dr. Vladimir Marquez, Vancouver, BC |
11:35 AM – 11:40 AM | Questions & Answers |
11:40 AM – 11:55 AM | Management of Liver Disease: Ascites, Portal Hypertension, Biliaryobstruction – Dr. Jason Wong, Calgary, AB |
11:55 AM – 12:00 PM | Questions & Answers |
12:00 PM – 1:00 PM | Lunch – Frontenac Ballroom C |
1:00PM – 5:10PM | Pancreas – Chair: Dr. Peter Kim – Frontenac Ballroom AB |
1:00 PM – 1:15 PM | Introduction and Cases – Dr. Peter Kim, Dr. V. Maltais, Dr. R. Gilbert, Dr P. Leung |
1:20 PM – 1:35 PM | Pancreatic Cancer: State of the Union – Dr. Daniel Renouf, Vancouver, BC |
1:35 PM – 1:40PM | Questions & Answers |
1:40 PM – 1:55 PM | Current State of the Art: External Beam Radiotherapy for Pancreas Carcinoma – Dr. Navesh K. Sharma, Penn State, PA |
1:55 PM – 2:00 PM | Questions & Answers |
2:00 PM – 2:15 PM | Surgical Resection and Curative Intent Patient Optimization – Dr. Sean Cleary, Rochester, MN |
2:15 PM – 2:20 PM | Questions & Answers |
2:20 PM – 2:35 PM | IR, IRE, PAI: Current and Future Roles for IR in Pancreatic Cancer – Dr. Govindarajan Narayanan, Miami, FL |
2:35 PM – 2:40 PM | Questions & Answers |
2:40 PM – 2:55 PM | Surgical Resection for Borderline Resectable/Locally Advanced Pancreas Cancer – Dr. Sean Cleary, Rochester, MN |
2:55 PM – 3:00 PM | Questions & Answers |
3:00 PM – 3:15 PM | Refreshment Break – Frontenac Foyer |
3:15 PM – 3:30 PM | Pancreatic Cancer: The Multidisciplinary Team – Dr. Daniel Renouf, Vancouver, BC |
3:30 PM – 3:35 PM | Questions & Answers |
3:35 PM – 3:50 PM | External Beam Radiation & Y90: Safety, Sequence & Recommendations – Dr. Kyle Cuneo, Ann Arbor, MI |
3:50 PM- 3:55 PM | Questions & Answers |
3:55 PM – 4:30 PM | Panel: Complex Surgical Reconstruction When, How and Why – Chair: Dr. I. McGilvray Panelists: Dr. S. Cleary, Dr. K. Cuneo, Dr. D. Renouf, Dr. G. Narayanan |
4:35 PM – 5:10 PM | Panel Cases – Chair: Dr. P. Kim Panelists: Dr. S. Cleary, Dr. A. Kennedy, Dr. G. Narayanan, Dr. D. Renouf |
5:10 PM – 5:20 PM | Closing Remarks |
Saturday, January 28, 2023
6:30 AM – 7:30 AM |
Breakfast- Frontenac Ballroom C |
7:30 AM – 7:45 AM | Introductions – Dr. David Liu, Vancouver, BC – Frontenac Ballroom AB |
7:30 AM – 11:50 AM |
HCC Part 2 – Consensus and Sequencing – Chair: Dr. David Liu, Vancouver, BC |
7:50 AM – 8:05 AM | Surgical HCC Consensus Statements HCC – Dr. Peter Kim, Vancouver, BC |
8:05 AM – 8:10 AM | Questions & Answers |
8:10 AM – 8:25 AM | Med Onc Consensus Statements – Dr. Howard Lim, Vancouver, BC |
8:25 AM – 8:30 AM | Questions & Answers |
8:30 AM – 8:45 AM | Addressing the Clinical Unmet Needs in HCC – Dr. David Liu, Vancouver, BC |
8:45 AM – 8:50 AM | Questions & Answers |
8:50 AM – 9:25 AM | Panel: Sequencing and Timing of Systemic vs LRT – Chair: Dr. H. Lim Panelists: Dr. A. Kennedy, Dr. P. Kim, Dr. D. Liu, Dr. V. Marquez |
9:30 AM – 9:45 AM | CAIR Consensus Statement – Dr. Jason Wong, Calgary, AB |
9:45 AM – 9:50 AM | Questions & Answers |
9:50 AM – 10:05 AM | Refreshment Break – Frontenac Foyer |
10:05 AM- 10:40 AM | Panel: Adjuncts to Surgery and Getting to Cure – Chair: Dr. Peter Kim Panelists: Dr. S. Cleary, Dr. H. Lim, Dr. N. Sharma, Dr. J. Wong |
10:40 AM – 10:55 AM | Current State of the Art: External Beam Radiotherapy for Hepatocellular Carcinoma – Dr. Kyle Cuneo, Ann Arbor, MI |
10:55 AM – 11:00 AM | Questions & Answers |
11:00 AM – 11:35 AM | Panel Cases – Chair: Dr. D. Liu Panelists: Dr. K. Cuneo, Dr. H. Lim, Dr. V. Marquez, Dr. I. McGilvray, Dr. J. Wong |
11:35 AM – 11:50 AM | Final Comments and Close – Dr. Wendy Lam |